Delays in operative management of early-stage, estrogen receptor–positive breast cancer during the COVID-19 pandemic: A multi-institutional matched historical cohort study

BACKGROUND: During the COVID-19 pandemic, guidelines recommended that breast cancer centers delay estrogen receptor–positive breast cancer surgeries with neoadjuvant endocrine therapy. We aimed to evaluate pathologic upstaging of breast cancer patients affected by these guidelines. METHODS: Female p...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lena, Élise, Hopkins, Brent, Wong, Stephanie M., Meterissian, Sarkis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Surgical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531248/
https://www.ncbi.nlm.nih.gov/pubmed/34862071
http://dx.doi.org/10.1016/j.surg.2021.10.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531248/
https://www.ncbi.nlm.nih.gov/pubmed/34862071
http://dx.doi.org/10.1016/j.surg.2021.10.033

Ejemplares similares